Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pediatrics/Neonatology | Pulmonary/Respiratory Diseases | Immunology/Infectious Diseases
Disease Category: Respiratory Syncytial Virus (RSV) Infection

Trial Information

RSV Vaccine

The purpose of this study is to evaluate the safety, immune response and viral shedding of MEDI-559, an investigational nasal vaccine being developed for RSV compared to a placebo, in infants 5 to 11 months old.

Patient Inclusion Criteria:

• Participants must be between 5 and 11 months old.
• Participants must be the result of a normal, full-term pregnancy.
• Participants must be in general good health.

Central Kentucky Research Associates
3475 Richmond Road, 3rd Floor
Lexington, KY 40509
Phone: 859-264-8999 or 1-800-898-1966

View Google Map

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.